Skip to content

Ketamine: all studies

Page 134 of 449: studies 1,331 to 1,340 of 4,486, newest first. Back to the ketamine overview

Research

Ketamine as Treatment for Cluster Headache: A Systematic Review of Literature and a Case Series.

Pain and therapy June 1, 2024 Johannes Neumann, Helmar Bornemann-Cimenti, Gudrun Rumpold-Seitlinger et al. 3 citations

Cluster headache is a severe and debilitating neurological condition characterized by intense, excruciating pain with a significant impact on patients' wellbeing. Although different treatment options are available, many patients continue to experience inadequate relief. Therefore, experimental strategies are increasingly studied. One of the more promising approaches is the use of ketamine. We...

DOI: 10.1007/s40122-024-00606-5 (opens in new tab) Full text (opens in new tab) Quality of life Systematic review Treatment Cluster headaches +4

Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie June 1, 2024 Xue Wu, Gehua Wen, Lei Yan et al. 11 citations

Ketamine, as a non-competitive antagonist of N-methyl-D-aspartate (NMDA) receptors, was originally used in general anesthesia. Epidemiological data show that ketamine has become one of the most commonly abused drugs in China. Ketamine administration might cause cognitive impairment; however, its molecular mechanism remains unclear. The glymphatic system is a lymphoid system that plays a key...

Sphincter of oddi dysfunction induced by ketamine: A case report.

Clinical Case Reports June 1, 2024 Nava Raj Sharma, Arjun Basnet, Saral Lamichhane et al. 4 citations

Chronic ketamine use can lead to sphincter of oddi dysfunction (SOD), causing various hepatobiliary complications. Recognizing substance abuse history is vital for early detection. Timely intervention can prevent irreversible liver and pancreas damage. Ketamine is commonly abused as a recreational drug worldwide due to its ability to induce euphoria-like effects. Ketamine abuse is associated...

DOI: 10.1002/ccr3.9016 (opens in new tab) Full text (opens in new tab) Biliary diseases Drug abuse Low‐dose ketamine Ketamine effects +2

Subanesthetic Ketamine Suppresses Locus Coeruleus-Mediated Alertness Effects: A 7T fMRI Study.

The International Journal of Neuropsychopharmacology June 1, 2024 Thomas Liebe, Lena Vera Danyeli, Zümrüt Duygu Sen et al. 5 citations

The NMDA antagonist S-ketamine is gaining increasing use as a rapid-acting antidepressant, although its exact mechanisms of action are still unknown. In this study, we investigated ketamine in respect to its properties toward central noradrenergic mechanisms and how they influence alertness behavior. We investigated the influence of S-ketamine on the locus coeruleus (LC) brain network in a...

DOI: 10.1093/ijnp/pyae022 (opens in new tab) Full text (opens in new tab) Lc functional connectivity Locus coeruleus Ultra-High Field MRI Ketamine therapy +4

Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems.

Journal of Psychopharmacology June 1, 2024 Emily M Gent, Joshua W. Bryan, Maisy A Cleary et al. 20 citations

Alcohol use disorder (AUD) is a major public health issue, posing harmful consequences for individuals and society. Recent advances in addiction research have highlighted the therapeutic potential of ketamine-assisted therapy for AUD. However, the exact mechanisms underlying its effectiveness remain unknown. This double-blind, pilot study aimed to investigate esketamine combined with...

Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression.

Brain and Behavior June 1, 2024 Brandon Taraku, Joana R Loureiro, Ashish K Sahib et al. 11 citations

Major depressive disorder (MDD) is associated with dysfunctional reward processing, which involves functional circuitry of the habenula (Hb) and nucleus accumbens (NAc). Since ketamine elicits rapid antidepressant and antianhedonic effects in MDD, this study sought to investigate how serial ketamine infusion (SKI) treatment modulates static and dynamic functional connectivity (FC) in Hb and NAc...

Is there evidence for using ketamine among individuals with dementia?

Journal of International Medical Research June 1, 2024 Arushi Kapoor, Tanya Peguero Estevez, Carol Chan et al. 11 citations

The aim of this short narrative review was to evaluate the existing literature regarding the clinical use of ketamine among individuals with dementia, especially those with behavioral disturbances. PubMed, Cochrane, and Ovid (Embase, APA PsycINFO, and MEDLINE) databases were searched for abstracts using the search terms "ketamine" AND "dementia." Only articles describing the use of ketamine in...

The Involvement of the Serotonergic System in Ketamine and Fluoxetine Combination-induced Cognitive Impairments in Mice.

The Eurasian journal of medicine June 1, 2024 Emre Uyar, Meral Erdinç, İlker Kelle et al.

Glutamatergic N-methyl-D-aspartate (NMDA) receptors play vital roles in memory formation. Changes in the activity of these receptors influence memory processes. Ketamine is a noncompetitive NMDA receptor antagonist drug with promising mood-altering and pain-reducing effects in low doses. These effects are believed to be related to altered serotonergic transmission. The present study...

DOI: 10.5152/eurasianjmed.2024.23219 (opens in new tab) Full text (opens in new tab) Psychopharmacology Mental health Drug interactions Memory research

Quantium Consciousness Index and Quantium Noxious Index in Ketamine Subdose Administration Compared with Fentanyl and Midazolam in Postoperative ICU Patients: A Prospective, Observational Study.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine June 1, 2024 Alegra R Masharto, Andriamuri P Lubis, Chrismas G Bangun et al. 1 citation

In postoperative patients in the intensive care units (ICUs), not only analgesics are needed but also sedation so that the patient can remain calm during treatment, especially patients with mechanical ventilation. By using the measurement parameters of the quantum consciousness index (qCON) and quantum noxious index (qNOX) in measuring the depth of sedation and adequacy of analgesics, the use...

Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study.

Psychedelic Medicine June 1, 2024 Ryan Yermus, John Bottos, Nathan Bryson et al. 13 citations

Ketamine-assisted psychotherapy (KAP) is an emerging treatment option to alleviate treatment-resistant affective disorders, but its long-term effectiveness remains unclear. To examine the treatment effects of KAP on anxiety, depression, and post-traumatic stress disorder (PTSD) at 1, 3, and 6 months post-treatment. This retrospective effectiveness study included self-reported outcomes from...